NCT01196442

Electrical Stimulation Pain Therapy in Treating Chronic Pain and Numbness Caused By Chemotherapy in Patients With Cancer

An Expanded Trial of MC5-A Calmare Therapy in the Treatment of Cancer Pain Syndromes and Chronic Chemotherapy-Induced Peripheral Neuropathy Including Pain and Numbness

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 39 (actual)
• Sponsor: Virginia Commonwealth University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

RATIONALE: Electrical stimulation pain therapy may help relieve chronic pain and numbness caused by chemotherapy. PURPOSE: This pilot trial studies electrical stimulation pain therapy in treating chronic pain and numbness caused by chemotherapy in patients with cancer.

Detailed description

OBJECTIVES: I. To evaluate the effect of MC5-A on pain symptoms both immediately and over time. II. To evaluate the effect of Calmare therapy on other non-pain symptoms. III. To evaluate the effect of MC5-A on daily opioid and other pain medication use. OUTLINE: Patients undergo electric stimulation pain therapy comprising MC5-A Calmare therapy over 30 minutes once daily for 10 days. After completion of study treatment, patients are followed up for 3 months.

Conditions

• Cancer-related Problem/Condition
• Neurotoxicity
• Pain
• Peripheral Neuropathy

Interventions

Type	Name	Description
OTHER	electrical stimulation pain therapy	Electrical stimulation pain therapy for 45 minutes on Day 1, then 30 minutes Days 2-10
OTHER	questionnaire administration	Brief Pain Inventory questionnaire administration at baseline, weekly, then monthly for 3 months

Timeline

• Start date: 2010-09-01
• Primary completion: 2012-09-01
• Completion: 2013-01-01
• First posted: 2010-09-08
• Last updated: 2013-08-23
• Results posted: 2013-02-12

Locations

1 site across 1 country: United States